Search

Your search keyword '"Sumpton, David"' showing total 250 results

Search Constraints

Start Over You searched for: Author "Sumpton, David" Remove constraint Author: "Sumpton, David"
250 results on '"Sumpton, David"'

Search Results

2. Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma

3. ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota

5. Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target

7. PKM2 diverts glycolytic flux in dependence on mitochondrial one-carbon cycle

8. Hepatic glutamine synthetase controls N5-methylglutamine in homeostasis and cancer

9. Absent expansion of AXIN2+ hepatocytes and altered physiology in Axin2CreERT2 mice challenges the role of pericentral hepatocytes in homeostatic liver regeneration

11. Nutrient-sensitizing drug repurposing screen identifies lomerizine as a mitochondrial metabolism inhibitor of chronic myeloid leukemia

12. Metabolic adaptations of micrometastases alter EV production to generate invasive microenvironments

13. Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix

16. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer

17. The pathogenesis of mesothelioma is driven by a dysregulated translatome

18. Author Correction: Cancer-associated fibroblasts require proline synthesis by PYCR1 for the deposition of pro-tumorigenic extracellular matrix

23. Mass Spectrometric Studies Of The Rhizobium-Legume Symbiosis

24. Arginine dependency is a therapeutically exploitable vulnerability in chronic myeloid leukaemic stem cells

27. 2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer

29. Supplementary Methods from Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress

30. Supplementary Table 3 from Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress

31. Data from Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress

32. Figures S1-S6 & Tables S1 & S2 from Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress

33. Data from SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer

34. Data from Rho Kinase Inhibition by AT13148 Blocks Pancreatic Ductal Adenocarcinoma Invasion and Tumor Growth

36. Supplemental Figures S1 to S5 from Rho Kinase Inhibition by AT13148 Blocks Pancreatic Ductal Adenocarcinoma Invasion and Tumor Growth

38. Supplementary Data from Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression

39. Supplementary Data 2 from SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer

40. Supplementary Information from SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer

41. Data from Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression

42. Tumour mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade

43. Metabolic profiling stratifies colorectal cancer and reveals adenosylhomocysteinase as a therapeutic target

45. PKM2 diverts glycolytic flux in dependence on mitochondrial one-carbon cycle

47. Hepatic glutamine synthetase controls N5-methylglutamine in homeostasis and cancer

48. Mesenchymal stromal cells cultured in physiological conditions sustain citrate secretion with glutamate anaplerosis

49. Phase II proof‐of‐concept study of atorvastatin in castration‐resistant prostate cancer

50. Cyclocreatine Suppresses Creatine Metabolism and Impairs Prostate Cancer Progression

Catalog

Books, media, physical & digital resources